The Federal Emergency Management Agency on Wednesday opened applications for a major resilience grant program that the agency canceled last year, less than three weeks after a federal judge ordered ...

This is read by an automated voice. Please report any issues or inconsistencies here. A select panel of L.A. County judges now have access to an artificial intelligence tool that can help them ...

Here's your look at the Stack Story announcement trailer for this upcoming narrative-driven roguelite deckbuilder game. Face unique bosses and uncover an intricate story in Stack Story. Upgrade and ...

A frozen federal program that pumped $4 billion a year into small and mid-sized tech businesses is on the brink of being reopened now that two US senators who sparred over its future, Ed Markey and ...

The Plain Dealer, Cleveland’s largest newspaper, has begun to feature a new byline. On recent articles about an ice carving festival, a medical research discovery and a roaming pack of chicken-slaying ...

When it comes to adapting to the consequences of climate change, the federal government has relied heavily on one flagship program: Building Resilient Infrastructure and Communities, or BRIC.

Rady Children’s Hospital must continue to provide “gender-affirming care” for patients under 19, a judge ruled Wednesday in a lawsuit filed by the state. After Rady announced last month that it would ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Last month the U.S. Energy Secretary discussed the state of the global energy sector, including a growing divergence between American and European policies, with WSJ Deputy Editor in Chief David Crow.

The romance industry, always at the vanguard of technological change, is rapidly adapting to A.I. Not everyone is on board. By Alexandra Alter Last February, the writer Coral Hart launched an ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...